packageLumasiran

lumasiran

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lumasiran, a small interfering RNA medicine, is used to treat primary hyperoxaluria. It is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q100692768 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lumasiran
ATC codes:A16AX18
DrugBank:DB15935
Wikidata:Q100692768
molar mass:16338.5 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown